| scholarly article | Q13442814 |
| P50 | author | Stepan Gambaryan | Q40206073 |
| P2093 | author name string | Ulrich Walter | |
| Natalia Rukoyatkina | |||
| Albert Smolenski | |||
| Anna Kobsar | |||
| Joerg Geiger | |||
| Sabine Herterich | |||
| Suzanne M Lohmann | |||
| P2860 | cites work | Protein phosphatase 2A interacts with and directly dephosphorylates RelA | Q24291769 |
| Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex | Q24297449 | ||
| PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation | Q24301041 | ||
| Anticoagulant and antithrombotic properties of platelet protease nexin-1 | Q24310458 | ||
| Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway | Q28202626 | ||
| Identification of 14-3-3zeta as a protein kinase B/Akt substrate | Q28214915 | ||
| Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets | Q28217479 | ||
| Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells | Q43559376 | ||
| Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets | Q44151468 | ||
| NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity | Q44626143 | ||
| Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. | Q44673838 | ||
| Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. | Q44714826 | ||
| Disabled-2 is a novel IIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation | Q57375290 | ||
| Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
| Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis | Q73281156 | ||
| Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets | Q77147370 | ||
| c-Src interacts with and phosphorylates RelA/p65 to promote thrombin-induced ICAM-1 expression in endothelial cells | Q79166171 | ||
| Canonical Wnt signaling negatively regulates platelet function | Q28510525 | ||
| Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 | Q28619230 | ||
| G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2 | Q29347516 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell | Q31036312 | ||
| The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism | Q33292331 | ||
| Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action | Q33732652 | ||
| Platelets and megakaryocytes contain functional nuclear factor-kappaB. | Q33782701 | ||
| Cyclic nucleotides and phosphodiesterases in platelets | Q33800099 | ||
| Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets. | Q34381692 | ||
| Taming platelets with cyclic nucleotides | Q34436565 | ||
| Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets. | Q34718342 | ||
| mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. | Q35642870 | ||
| Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A. | Q35989423 | ||
| Tracking functions of cGMP-dependent protein kinases (cGK). | Q36071677 | ||
| Adhesion mechanisms in platelet function | Q36856340 | ||
| Mechanics of proplatelet elaboration | Q36884299 | ||
| Cyclic AMP signaling and gene regulation | Q36898041 | ||
| Unresolved roles of platelet nitric oxide synthase | Q36974994 | ||
| Platelet activation and atherothrombosis | Q37031278 | ||
| Cell adhesion mechanisms in platelets | Q37049884 | ||
| Acute activation of NHE3 by dexamethasone correlates with activation of SGK1 and requires a functional glucocorticoid receptor | Q37225408 | ||
| cGMP and cGMP-dependent protein kinase in platelets and blood cells. | Q37352810 | ||
| cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes | Q37886477 | ||
| NF-kappaB inhibitors impair platelet activation responses | Q38352662 | ||
| Efficient nuclear export of p65-IkappaBalpha complexes requires 14-3-3 proteins. | Q40239759 | ||
| Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta | Q40337760 | ||
| A novel mechanism of G protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein | Q40392883 | ||
| Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta | Q40545229 | ||
| Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes | Q40558422 | ||
| Structure and function of cyclic nucleotide-dependent protein kinases | Q40660658 | ||
| Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets | Q40765799 | ||
| Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells | Q41083638 | ||
| NFkappaB regulation of platelet function: no nucleus, no genes, no problem? | Q41769481 | ||
| Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets. | Q41808295 | ||
| Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. | Q41831428 | ||
| Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation | Q41928597 | ||
| Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle | Q42497456 | ||
| Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. | Q42909234 | ||
| A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations | Q43242551 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 18352-18363 | |
| P577 | publication date | 2010-03-31 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex | |
| P478 | volume | 285 |
| Q35672398 | A novel role of sesamol in inhibiting NF-κB-mediated signaling in platelet activation |
| Q43125680 | A sticky story for signal transducer and activator of transcription 3 in platelets. |
| Q37631402 | Antiplatelet Activity of Morus alba Leaves Extract, Mediated via Inhibiting Granule Secretion and Blocking the Phosphorylation of Extracellular-Signal-Regulated Kinase and Akt. |
| Q26830366 | Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles |
| Q61800023 | Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis |
| Q37127241 | Chlorin e6 Prevents ADP-Induced Platelet Aggregation by Decreasing PI3K-Akt Phosphorylation and Promoting cAMP Production. |
| Q91723015 | Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction |
| Q53271322 | Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP. |
| Q37899788 | Cyclic AMP: a selective modulator of NF-κB action. |
| Q64929172 | Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses. |
| Q24309320 | Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling |
| Q28081339 | Drosophila blood cells and their role in immune responses |
| Q35140258 | Echicetin coated polystyrene beads: a novel tool to investigate GPIb-specific platelet activation and aggregation |
| Q34865151 | Effect of Cordycepin-Enriched WIB801C from Cordyceps militaris Suppressing Fibrinogen Binding to Glycoprotein IIb/IIIa |
| Q44750844 | Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets |
| Q42361627 | Erythrocytes do not activate purified and platelet soluble guanylate cyclases even in conditions favourable for NO synthesis |
| Q36252847 | Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. |
| Q38109969 | Harnessing the platelet signaling network to produce an optimal hemostatic response. |
| Q35161186 | Hyperthermia inhibits platelet hemostatic functions and selectively regulates the release of alpha-granule proteins |
| Q52718186 | Immunology. Danger, microbes, and homeostasis. |
| Q97539456 | Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS |
| Q41831369 | In Vitro and Ex Vivo Approaches to Evaluate Next-Generation Tobacco and Non-Tobacco Products on Human Blood Platelets |
| Q36861329 | Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser(157) phosphorylation on thrombin-induced platelet aggregation |
| Q89779307 | IκB kinase 2 is not essential for platelet activation |
| Q28114792 | IκB kinase phosphorylation of SNAP-23 controls platelet secretion |
| Q37327376 | Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase. |
| Q48217726 | Lighting up kinase action in platelets |
| Q41981484 | MKP-1 negative regulates Staphylococcus aureus induced inflammatory responses in Raw264.7 cells: roles of PKA-MKP-1 pathway and enhanced by rolipram |
| Q33636409 | Mechanism of PKA-dependent and lipid-raft independent stimulation of Connexin43 expression by oxytoxin in mouse embryonic stem cells |
| Q37625592 | NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets |
| Q35120893 | NF-κB addiction and its role in cancer: 'one size does not fit all'. |
| Q36275478 | Natural formulas and the nature of formulas: Exploring potential therapeutic targets based on traditional Chinese herbal formulas |
| Q36699681 | Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells |
| Q37964007 | Novel roles of cAMP/cGMP-dependent signaling in platelets. |
| Q37662870 | Pannexin3 inhibits TNF-α-induced inflammatory response by suppressing NF-κB signalling pathway in human dental pulp cells |
| Q51049232 | Phosphorylation of CalDAG-GEFI by protein kinase A prevents Rap1b activation. |
| Q30500885 | Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. |
| Q38044999 | Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets. |
| Q37807427 | Platelet physiology and antiplatelet agents |
| Q38362628 | Platelet transfusion - the new immunology of an old therapy |
| Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
| Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
| Q28085020 | Platelets in inflammation and atherogenesis |
| Q36078727 | Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα). |
| Q36158964 | Prostanoid EP₁ receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB. |
| Q33443097 | Protein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis |
| Q35843116 | Proteolytic regulation of the mitochondrial cAMP-dependent protein kinase |
| Q42290465 | RXR Ligands Negatively Regulate Thrombosis and Hemostasis. |
| Q42547484 | Reply to Schattner. |
| Q47693330 | Retinoic acid receptor-α regulates synthetic events in human platelets |
| Q92959413 | Role of NF-κB in Platelet Function |
| Q36274845 | The ABCC4 membrane transporter modulates platelet aggregation. |
| Q34042836 | The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies |
| Q36619777 | The oligopeptide DT-2 is a specific PKG I inhibitor only in vitro, not in living cells |
| Q43119916 | The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood |
| Q40713949 | Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation. |
| Q41620783 | Variations in Intraplatelet Phospho-VASP Expression Due to Pre-analytical Sample Preparations, Illustration of a Quality Control Issue in Platelet Pharmacology |
| Q37314349 | Vasodilator-stimulated phosphoprotein-phosphorylation by ginsenoside Ro inhibits fibrinogen binding to αIIb/β3 in thrombin-induced human platelets |
Search more.